Dr. Santi Yarlagadda, MD

Dr. Yarlagadda practices at Community Hospital of the Monterey Peninsula in Monterey, California, part of Montage Health.

Dr. Yarlagadda's NPI, 1699086827, was assigned on June 22, 2010. Dr. Yarlagadda graduated from Albany Medical College in 2010. Dr. Yarlagadda holds California license A148602.

Dr. Yarlagadda's primary practice is Community Hospital of the Monterey Peninsula, at 23625 W R Holman Highway, Monterey, CA 93940 in Monterey County. The practice phone is (831) 624-5311.

Dr. Yarlagadda's primary practice is Community Hospital of the Monterey Peninsula in Monterey, California, part of Montage Health. Dr. Yarlagadda is also affiliated with Salinas Valley Health Medical Center. The medical group on file is Montage Medical Group. Dmand AI also links Dr. Yarlagadda to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yarlagadda practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Yarlagadda's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Yarlagadda is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Yarlagadda's licenses on file in 4 states: California, Colorado, Texas and Illinois.

Dmand AI lists atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart failure, heart valve disorders, high cholesterol and intermittent racing heartbeat (PSVT) among the conditions Dr. Yarlagadda treats.

CMS data shows 320 Medicare services from Dr. Yarlagadda across 7 procedure codes in 2024, for 214 Medicare patients. Medicare paid $32,806 for them.

CMS counts 214 Medicare patients who saw Dr. Yarlagadda in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yarlagadda's median patient age at 67, with 53% women.

In 2024, Dr. Yarlagadda wrote 913 Medicare Part D claims for 126 patients. 78% of them were for generic drugs. CMS names the drug for 798 of them, across 20 drugs with 11 or more claims each, at $732,961 in total drug cost. In 2023, CMS named 717 claims across 18 drugs.

Dr. Yarlagadda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yarlagadda as offering telehealth.

Dmand AI links 2 papers to Dr. Yarlagadda in 2016. Dr. Yarlagadda's most frequent co-authors are Asif Ali, MD, Jonathan Louis Hassel, MD and John Patrick Higgins, MD.

CMS Open Payments shows 175 general payments to Dr. Yarlagadda from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Abbott Laboratories paid the most, $8,856.

Dr. Yarlagadda graduated from Albany Medical College in 2010.

Dr. Yarlagadda is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.